U.S. Beverage Alcohol Forum to Debut at WSWA Convention

The U.S. Beverage Alcohol Forum (USBAF) will premiere on April 5 at the WSWA 69th Annual Convention & Exposition in Las Vegas. The USBAF is a partnership between Wine & Spirits Wholesalers of America (WSWA) and the U.S. Drinks Conference (USDC) to offer educational sessions for suppliers and wholesalers. The newly created U.S. Beverage Alcohol Forum will offer business-related sessions from 12:30 to 4:30 p.m. at Caesars Palace.

“The educational sessions were a big hit last year at the WSWA Convention & Exposition. The attendees found that the sessions provided tremendous insight that they could leverage in their businesses,” explained Craig Wolf, WSWA president and CEO.

Sessions for the event will focus on subjects including social media, brand activation, industry trends and brand building, as well as a presentation of the latest industry data. It will conclude with the session: Building, Cultivating and Retaining a World-Class Team.

“The goals for the Forum are to provide the practical information suppliers need to know to successfully enter and grow in the U.S. market and also to present effective business solutions for wholesalers,” added Steven Raye of Brand Action Team, one of the founding companies of the U.S. Drinks Conference, along with Next Level Marketing and MHW Ltd.

Forum sponsors include media partners: Beverage Media Group, Beverage Information Group, Tasting Panel Magazine, Nightclub & Bar Media Group and Bar Business Magazine, along with Nixon Peabody LLP, Western Carriers, JF Hillebrand, Overton, Mast Capital Partners and Kuehne + Nagel.

Participants who register for the WSWA Convention & Exposition will receive complimentary access to the U.S. Beverage Alcohol Forum. One-day passes to this event are also available. Visit www.wswaconvention.org for registration information.


Suggested Articles

A breakdown of the latest $1 trillion from the Senate.

The number of businesses switching from temporary to permanent closures surpasses 50%.

The coronavirus continues to threaten our industry but there are promising medical developments and still many questions on the next round of relief.